Anjali Narayan Avadhani
-
- Colorectal Cancer Treatments and Studies 3
-
- Bladder and Urothelial Cancer Treatments 6
- Urinary and Genital Oncology Studies 4
-
- Prostate Cancer Treatment and Research 4
- Renal cell carcinoma treatment 2
-
- Fibroblast Growth Factor Research 8
-
- Cancer Genomics and Diagnostics 3
-
- Radiopharmaceutical Chemistry and Applications 3
- Co-authors
- Anne O’HaganArlene O. Siefker‐RadtkeYohann LoriotEarle F. BurgessBegoña MelladoPeter De PorreAndrea NecchiBob Zhong
- Partner nations
- United StatesBelgiumSpain
In The Last Decade
Anjali Narayan Avadhani
19 papers receiving 177 citations
Peers
Comparison fields: 5 of 43
- Oncology 64
- Surgery 95
- Pulmonary and Respiratory Medicine 42
- Molecular Biology 87
- Cancer Research 10
Countries citing papers authored by Anjali Narayan Avadhani
This map shows the geographic impact of Anjali Narayan Avadhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anjali Narayan Avadhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anjali Narayan Avadhani more than expected).
Fields of papers citing papers by Anjali Narayan Avadhani
This network shows the impact of papers produced by Anjali Narayan Avadhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anjali Narayan Avadhani. The network helps show where Anjali Narayan Avadhani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anjali Narayan Avadhani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2022 | 7 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 10 | |
| 6 | 2021 | 0 | |
| 7 | 2019 | 3 | |
| 8 | 2018 | 24 | |
| 9 | 2018 | 54 | |
| 10 | 2018 | 11 | |
| 11 | 2016 | 3 | |
| 12 | 2016 | 6 | |
| 13 | 2013 | 21 | |
| 14 | 2008 | 7 | |
| 15 | 2008 | 2 | |
| 16 | 2007 | 2 | |
| 17 | 2007 | 4 | |
| 18 | Colorectal cancer treatment in the elderly: tailored therapy approaches. | 2007 | 1 |
| 19 | 2004 | 8 | |
| 20 | 2002 | 9 |
About Anjali Narayan Avadhani
Anjali Narayan Avadhani is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, having authored 20 papers that have together received 178 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (8 papers), Bladder and Urothelial Cancer Treatments (6 papers), Urinary and Genital Oncology Studies (4 papers), Prostate Cancer Treatment and Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Genomics and Diagnostics (3 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Oncology (64 citations), Surgery (95 citations) and Pulmonary and Respiratory Medicine (42 citations). Anjali Narayan Avadhani has collaborated with scholars based in United States, Belgium and Spain. Frequent co-authors include Anne O’Hagan, Arlene O. Siefker‐Radtke, Yohann Loriot, Earle F. Burgess, Begoña Mellado, Peter De Porre, Andrea Necchi, Bob Zhong, Sergei Varlamov and Se Hoon Park. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.